EP
EOLS icon

Essential Partners’s Evolus EOLS Stock Holding History

Essential Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6K Sell
231
-164
-42% -$968 ﹤0.01% 2062
2026
Q1 		$1.62K Buy
+395
New +$1.91K ﹤0.01% 2083

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Essential Partners's EOLS Position: Q2 2026 in Review

Essential Partners reduced its Evolus (EOLS) stake by 42% in Q2 2026, selling an estimated $968 and leaving 231 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Essential Partners first reported a position in EOLS in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.62K in Q1 2026. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Essential Partners held 231 shares of Evolus worth $1.6K as of Q2 2026.
  • Essential Partners sold 164 Evolus shares in Q2 2026, an estimated $968.
  • Evolus made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2062 holding.
  • Essential Partners first reported a position in Evolus in Q1 2026 and has held it in 2 quarters since.
  • Essential Partners's Evolus position peaked at $1.62K in Q1 2026.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.